Guadalupe Hayes-Mota is a biotechnology executive, bioethicist, and AI innovator whose work sits at the intersection of healthcare access, advanced manufacturing, and ethical technology. His career focuses on redesigning the systems that deliver medicine to patients, using artificial intelligence, operational strategy, and policy insight to build more resilient and equitable healthcare infrastructures worldwide.

Recognized for his leadership across industry, academia, and public service, Hayes-Mota has held global executive roles in biopharmaceutical supply chain and manufacturing at leading life science companies and founded an AI-enabled startup that optimized drug distribution across dozens of countries. He serves as Director of the Bioethics Program at Santa Clara University’s Markkula Center for Applied Ethics and as a Senior Lecturer at MIT, where he teaches biotechnology, ethics, and healthcare systems. He has been appointed to national advisory roles including the NIH Cures Acceleration Network Review Board and has been invited by the European Commission to contribute to projects examining the role of artificial intelligence in health emergency preparedness and response.

Hayes-Mota collaborates with universities, policymakers, healthcare leaders, and technology innovators to advance thoughtful, human-centered approaches to AI in medicine. He is also a published writer in Forbes, Fast Company, and STAT, where he explores the intersection of biotechnology, ethics, leadership, and access to care. Through his writing, teaching, and public speaking, he advocates for ethical innovation that prioritizes patient dignity, system resilience, and global access to medicines in an increasingly technological world.